Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1143)
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
240
Price
$51.48
Total Value
$12.36K
Shares Held After
25,000
% of Holdings
1.0%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
1,844
Price
$50.71
Total Value
$93.51K
Shares Held After
25,240
% of Holdings
6.8%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
2,916
Price
$50.03
Total Value
$145.89K
Shares Held After
27,084
% of Holdings
9.7%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
289
Price
$51.49
Total Value
$14.88K
Shares Held After
38,000
% of Holdings
0.8%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
2,194
Price
$50.72
Total Value
$111.27K
Shares Held After
38,289
% of Holdings
5.4%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
3,535
Price
$50.03
Total Value
$176.85K
Shares Held After
40,483
% of Holdings
8.0%
Medpace Holdings, Inc. (MEDP)
Troendle August J. — Director
Shares
10,880
Price
$620.40
Total Value
$6.75M
Shares Held After
504,273
% of Holdings
2.1%
Pharvaris N.V. (PHVS)
Lu Peng — President
Shares
100,000
Price
$35.00
Total Value
$3.50M
Shares Held After
64,953
% of Holdings
60.6%
Pharvaris N.V. (PHVS)
Schikan Johannes Gerardus Christiaan Petrus — Director
Shares
200,000
Price
$35.00
Total Value
$7.00M
Shares Held After
115,167
% of Holdings
63.5%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
869
Price
$163.39
Total Value
$141.99K
Shares Held After
620,589
% of Holdings
0.1%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
2,565
Price
$162.31
Total Value
$416.33K
Shares Held After
621,458
% of Holdings
0.4%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
11,169
Price
$161.49
Total Value
$1.80M
Shares Held After
624,023
% of Holdings
1.8%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
14,493
Price
$160.44
Total Value
$2.33M
Shares Held After
635,192
% of Holdings
2.2%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
23,884
Price
$159.53
Total Value
$3.81M
Shares Held After
649,685
% of Holdings
3.5%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
232,173
Price
$158.09
Total Value
$36.70M
Shares Held After
673,569
% of Holdings
25.6%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
32,260
Price
$157.49
Total Value
$5.08M
Shares Held After
905,742
% of Holdings
3.4%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
9,097
Price
$156.47
Total Value
$1.42M
Shares Held After
938,002
% of Holdings
1.0%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
13,378
Price
$155.46
Total Value
$2.08M
Shares Held After
947,099
% of Holdings
1.4%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
4,175
Price
$154.17
Total Value
$643.66K
Shares Held After
960,477
% of Holdings
0.4%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
3,399
Price
$153.40
Total Value
$521.42K
Shares Held After
964,652
% of Holdings
0.4%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
6,644
Price
$152.21
Total Value
$1.01M
Shares Held After
968,051
% of Holdings
0.7%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
2,440
Price
$151.46
Total Value
$369.57K
Shares Held After
974,695
% of Holdings
0.2%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
20,000
Price
$38.27
Total Value
$765.47K
Shares Held After
73,969
% of Holdings
21.3%
Pharvaris N.V. (PHVS)
Glassman Robert — Director
Shares
14,493
Price
$38.56
Total Value
$558.81K
Shares Held After
10,500
% of Holdings
58.0%
Pharvaris N.V. (PHVS)
Bjork Elisabeth — Director
Shares
52,500
Price
$37.89
Total Value
$1.99M
Shares Held After
15,167
% of Holdings
77.6%
Hims&Hers Health, Inc. (HIMS)
Okupe Oluyemi — Chief Financial Officer
Shares
12,313
Price
$28.82
Total Value
$354.86K
Shares Held After
251,804
% of Holdings
4.7%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
645
Price
$81.09
Total Value
$52.30K
Shares Held After
809,631
% of Holdings
0.1%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
6,855
Price
$80.52
Total Value
$551.96K
Shares Held After
810,276
% of Holdings
0.8%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
11,609
Price
$81.09
Total Value
$941.37K
Shares Held After
14,985,469
% of Holdings
0.1%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
123,391
Price
$80.52
Total Value
$9.94M
Shares Held After
14,997,078
% of Holdings
0.8%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
4,942
Price
$81.09
Total Value
$400.75K
Shares Held After
8,602,783
% of Holdings
0.1%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
52,558
Price
$80.52
Total Value
$4.23M
Shares Held After
8,607,725
% of Holdings
0.6%
Tempus AI, Inc. (TEM)
Bartolucci Ryan M — Chief Accounting Officer
Shares
7,062
Price
$75.00
Total Value
$529.65K
Shares Held After
60,804
% of Holdings
10.4%
Tempus AI, Inc. (TEM)
Polovin Andrew — EVP, Chief Legal Officer
Shares
2,951
Price
$75.00
Total Value
$221.32K
Shares Held After
135,189
% of Holdings
2.1%
Heartflow, Inc. (HTFL)
Verghese Vikram — Chief Financial Officer
Shares
7,579
Price
$50.11
Total Value
$379.82K
Shares Held After
171,949
% of Holdings
4.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$501.60
Total Value
$80.26K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
468
Price
$500.09
Total Value
$234.04K
Shares Held After
324,603
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
332
Price
$499.10
Total Value
$165.70K
Shares Held After
325,071
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
151
Price
$497.79
Total Value
$75.17K
Shares Held After
325,403
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,953
Price
$497.17
Total Value
$970.98K
Shares Held After
325,554
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,182
Price
$496.21
Total Value
$1.08M
Shares Held After
327,507
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,905
Price
$495.11
Total Value
$943.18K
Shares Held After
329,689
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,750
Price
$494.34
Total Value
$865.10K
Shares Held After
331,594
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
599
Price
$493.22
Total Value
$295.44K
Shares Held After
333,344
% of Holdings
0.2%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
34,000
Price
$98.60
Total Value
$3.35M
Shares Held After
519,209
% of Holdings
6.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
320
Price
$501.58
Total Value
$160.51K
Shares Held After
45,172
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
125
Price
$500.80
Total Value
$62.60K
Shares Held After
45,492
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,160
Price
$499.75
Total Value
$579.71K
Shares Held After
45,617
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
843
Price
$498.74
Total Value
$420.44K
Shares Held After
46,777
% of Holdings
1.8%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
700
Price
$104.39
Total Value
$73.07K
Shares Held After
0
% of Holdings
100.0%
Showing 251–300 of 1143 transactions (page 6 of 23)